10x Genomics Overview
10x Genomics Target Price
See 10x Genomics's analyst price targets ($68) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$67.52
Average Target Price
$68.06
0.8% upside
0.8% upside17 analysts in the last 4 months
High: $110 | Low: $37
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-10-13 | Stifel Nicolaus | $70 | 3.7% upside |  |
| 2026-10-12 | Morgan Stanley | $70 | 3.7% upside | |
| 2026-10-12 | Canaccord GenuityKyle Mikson | $100 | 48.1% upside | |
| 2026-10-07 | Barclays | $110 | 62.9% upside | |
| 2026-09-29 | Leerink Partners | $90 | 33.3% upside | |
| 2026-09-28 | Argus Research | $110 | 62.9% upside | |
| 2026-09-28 | Piper Sandler | $80 | 18.5% upside | |
| 2026-09-09 | UBSDoug Schenkel | $68 | 0.7% upside | |
| 2026-09-01 | RBC CapitalDan Leonard | $70 | 3.7% upside | |
| 2026-08-12 | StephensMason Carrico | $65 |  3.7% downside | |
| 2026-08-10 | Piper Sandler | $47 | 30.4% downside | |
| 2026-08-10 | Canaccord GenuityKyle Mikson | $60 | 11.1% downside | |
| 2026-08-07 | Morgan Stanley | $40 | 40.8% downside | |
| 2026-08-07 | Stifel Nicolaus | $50 | 25.9% downside | |
| 2026-07-17 | Leerink Partners | $40 | 40.8% downside | |
| 2026-07-14 | Canaccord GenuityKyle Mikson | $50 | 25.9% downside | |
| 2026-07-09 | Morgan StanleyKallum Titchmarsh | $37 | 45.2% downside | |
| 2026-06-24 | BarclaysLuke Sergott | $40 | 40.8% downside | |
| 2026-05-12 | Morgan Stanley | $22 | 67.4% downside | |
| 2026-04-14 | Barclays | $30 | 55.6% downside | |
| 2026-03-02 | Stifel NicolausDaniel Arias | $25 | 63% downside | |
| 2026-02-20 | UBS | $20 | 70.4% downside | |
| 2026-02-13 | Deutsche Bank | $17 | 74.8% downside | |
| 2026-02-13 | Stifel Nicolaus | $20 | 70.4% downside | |
| 2026-02-13 | Canaccord GenuityKyle Mikson | $22 | 67.4% downside | |
| 2026-01-12 | Needham | $21 | 68.9% downside | |
| 2025-12-22 | Canaccord Genuity | $20 | 70.4% downside | |
| 2025-12-15 | Barclays | $22 | 67.4% downside | |
| 2025-12-01 | Morgan StanleyKallum Titchmarsh | $20 | 70.4% downside | |
| 2025-08-11 | Canaccord GenuityKyle Mikson | $16 | 76.3% downside | |
| 2025-08-08 | UBSDan Leonard | $13 | 80.7% downside | |
| 2025-08-08 | Deutsche BankJustin Bowers | $14 | 79.3% downside | |
| 2024-08-13 | Morgan StanleyTejas Savant | $46 | 31.9% downside | |
| 2024-07-23 | Canaccord GenuityKyle Mikson | $32 | 52.6% downside | |
| 2024-07-10 | Deutsche BankJustin Bowers | $25 | 63% downside | |
| 2024-06-28 | BarclaysLuke Sergott | $24 | 64.5% downside | |
| 2024-06-03 | JefferiesTycho Peterson | $24 | 64.5% downside | |
| 2024-05-01 | BarclaysLuke Sergott | $36 | 46.7% downside | |
| 2024-04-10 | BarclaysLuke Sergott | $45 | 33.4% downside | |
| 2022-12-14 | Deutsche Bank | $50 | 25.9% downside | |